After Myron Cohen watched the first patient at UNC Hospitals die from AIDS in 1982, he knew it was a disease to be reckoned with. He spent the next 40 years helping to recruit the most promising infectious disease experts from across the nation to build a program that’s become a leader in HIV. Today, UNC excels in understanding all aspects of HIV, from prevention to a potential cure — expertise that is now being used to tackle COVID-19.
Senior Kaitlyn Tsai is an undergraduate researcher in the College of Arts & Sciences majoring in chemistry with a biochemistry focus and minoring in medical anthropology and biology. Her research involves conducting complex chemical reactions to better understand the chemistry behind biological processes such as cancer. After graduation this May, she will pursue a PhD at the University of California, San Francisco.
Brian Strahl and his band of biochemists unravel the complicated mysteries of the epigenetic code to find a culprit in cancer development.